Gut Registry

entity · release 2026-09-20

HMO

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Containing labels3
Evidence amount1.00
Direction balanceThe direction of the study results has not been extracted.

Matched PubMed records

39 records (retracted records excluded; 0 retracted records match the query separately). PubMed query

Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.

  1. 2026 · 2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial.
  2. 2026 · 2'-Fucosyllactose Effects on Preterm Growth, Tolerance, and Neurobehavior: A Double-Blind, Randomized, Placebo-Controlled Pilot.
  3. 2026 · Vitamin D and its role in human milk oligosaccharide production.
  4. 2025 · 2'-Fucosyllactose supplementation results in a transient improvement in gut microbial resilience after vancomycin use in adults with overweight or obesity: a randomized, double-blind, placebo-controlled intervention.
  5. 2025 · Effects of maternal allergy and supplementation with ω-3 fatty acid and probiotic on human milk oligosaccharides.
  6. 2025 · Bifidogenic Effect of 2'-Fucosyllactose (2'-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical Trial.
  7. 2024 · Effects of Human Milk Oligosaccharide 2'-Fucosyllactose Ingestion on Weight Loss and Markers of Health.
  8. 2023 · Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial.
  9. 2023 · An Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides Modifies the Fecal Microbiome and Metabolome in Infants with Cow's Milk Protein Allergy.
  10. 2023 · Infants Fed Breastmilk or 2'-FL Supplemented Formula Have Similar Systemic Levels of Microbiota-Derived Secondary Bile Acids.

and 29 more

ClinicalTrials.gov

60 interventional studies. ClinicalTrials.gov query

Axis 1 · inverted

Containing label versions

Showing 3 of 3 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.

BrandProductDSLDGut Index ScoreStrain namedGrams/serving printedPotency basisVersions
MetagenicsMetaKids Nutrition Powder Chocolate Flavor216415Not available in this release.falseundefined: light snapshotnot stated1
Culturelle KidsGrow + Thrive273848Not available in this release.falseundefined: light snapshotnot stated1
MetagenicsMetaKids Nutrition Powder Vanilla Flavor295766Not available in this release.falseundefined: light snapshotnot stated1

Axis 2

Studiedness

Evidence amount
1.00
Direction balance
The direction of the study results has not been extracted.
PMID records loaded
39
Records after title/year deduplication
39

Axis 3

Measurement integrity

Not a measurement product, so this axis does not apply.

Axis 4

Reddit mention panel

0 observed mentions; no aggregate panel matched this entity.

Elsewhere in this release

Related pages

Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps

Tools: DSLD product check · Unit value calculator

Citation

Cite this page

Ivitskiy, I. (2026). HMO. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/hmo/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

  1. HMO appears on 3 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 2 brands; rank 11 of 11 substances by distinct label count.

    3 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  2. 0 of 3 containing labels in the NIH DSLD snapshot (Sep 2026) print grams per serving for HMO (0.0%); 3 light records have quantities unavailable.

    0 / 3 containing labels · NIH DSLD snapshot Sep 2026 · entity.grams · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  3. 39 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 39 records (retracted records excluded; 0 retracted records match the query separately).

    Published PubMed query

    39 / 39 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  4. 60 interventional studies on ClinicalTrials.gov match the published query.

    Published ClinicalTrials.gov query

    60 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

  5. 0 of 3 SKUs containing HMO have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.

    0 / 3 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub